Our results suggest that a MnSOD-K68-Ac signature is associated with a poor clinical outcome in human breast cancer and thus, this signature may be a molecular biomarker in women with pathologically aggressive luminal B cancer. This evidence concerns the gene SOD2 and breast carcinoma.